Nobel Medicine Prize 2026: How scientists use light to control brain cells

Why in the News

Neuroscience has moved from having no way to switch on a single set of brain cells to turning chosen neurons on or off with light, a method called optogenetics. The 2026 Nobel Prize in Physiology or Medicine has gone jointly to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics”.

What is optogenetics?

1. Brain as a network: The brain is an electrical network of billions of neurons, whose signals let us move, see, remember and feel.
2. What it is: Optogenetics uses light to control genetically modified cells. Scientists make target cells carry light-sensitive proteins called opsins.
3. How it works: When light falls on those cells, the opsins act like tiny light switches, turning the cells’ activity on or off.
4. Precision: Scientists can switch one organ’s cells and watch how the brain responds. Eg. Deisseroth paced the heart and watched brain states.
5. The takeaway: Optogenetics “fundamentally altered our understanding of the brain”, so scientists can now test how it forms memories, feelings and behaviours.

How was the light switch discovered?

1. Crick’s idea: Francis Crick, co-discoverer of DNA’s double helix, wanted to activate single nerve cells to study consciousness, and saw light as the only tool fast enough.
2. A fast-reacting alga: Hegemann, of Humboldt University of Berlin, found the alga Chlamydomonas reacts within half a millisecond of light reaching its eyespot (light sensor). The human eye takes 10 milliseconds.
3. One protein hypothesis: He proposed that one protein both captures light and acts on it. Japanese researchers’ map of the alga’s DNA pointed to two candidate genes.
4. Confirmation in frog eggs: Nagel, of the University of Würzburg, put both genes into frog eggs. The sensor was channelrhodopsin-2 (ChR-2), a cell membrane pore that opens when lit.
5. Control of nerve cells: Deisseroth, of the Howard Hughes Medical Institute, used ChR-2 to control chosen nerve cells in a dish, then in live rats. Switches for other wavelengths followed.

What has optogenetics revealed about the brain?

1. Whiskers and sleep: In 2006, Deisseroth’s group used light to move mouse whiskers, and woke sleeping mice by switching on a newly found wakefulness cell.
2. Fear memory: The team marked the nerve cells that formed a fear memory. Reactivating them later made mice show fear with no danger present.
3. Mapped circuits: Optogenetics has identified circuits for pain, social behaviour, thirst, feeding, reward and attention, and shown how memories form.
4. One room at a time: A Tata Institute of Fundamental Research (TIFR) professor likens the brain to a building of many rooms. Optogenetics lights one room at a time.

Can optogenetics treat patients yet?

1. Mainly a lab tool: It is still used largely in laboratories to find which neurons drive animal behaviour and what causes certain conditions.
2. Restoring sight: Clinical trials are testing it on blindness from retinitis pigmentosa, which destroys the eye’s rods and cones. Wearing light-emitting glasses, one patient could grasp objects.
3. Better hearing: It could improve cochlear implants, which now stimulate the hearing nerve with electricity.

Challenges

1. Gene delivery: Each therapy must insert an opsin gene into human cells, usually through modified viruses, which raises safety questions.
2. Invasive light: Reaching deep brain cells needs implanted optical fibres.
3. Animal to human gap: Most findings come from mice and rats, whose brain circuits differ from human ones.
4. Ethics of control: Switching memories and behaviour on demand raises consent and misuse concerns.

Way Forward

1. Research funding: The Anusandhan National Research Foundation (ANRF) should fund Indian optogenetics laboratories.
2. Ethics rules: The Indian Council of Medical Research (ICMR) should extend its ethical guidelines to gene-based brain interventions.
3. Less invasive tools: Back opsins responding to red light, which passes deeper through tissue.
4. Clinical pathway: The Central Drugs Standard Control Organisation (CDSCO) should set a clear route for gene therapy trials.

Conclusion

Optogenetics has shifted neuroscience from watching the brain to testing it cell by cell, but it remains mostly a laboratory tool. Whether the vision trials succeed in patients will show how fast it moves from mice to medicine.

Back2Basics: Nobel Prize in Physiology or Medicine

1. Origin: Created by the will of Alfred Nobel and first awarded in 1901.
2. Selection: The Nobel Assembly at Karolinska Institutet, Stockholm, chooses the laureates.
3. Sharing: A single prize can be shared by at most three laureates.
4. Ceremony: Prizes are presented on 10 December, the anniversary of Nobel’s death.

Matching Previous Year Question

“[2026] ‘X’, born in the UK, was conferred the Nobel Prize in 2025. He was a professor in an American university when the prize was announced. Identify ‘X’: (a) Michel H. Devoret (b) Richard Robson (c) John Clarke (d) Joel Mokyr ANSWER: C”